The Federal Trade Commission (FTC) issued letters to 10 companies to warn them that certain drug patents were improperly listed; the US Department of Agriculture (USDA) will begin testing ground beef for bird flu particles; rural Americans are more likely to die early from 1 of the 5 leading causes of death than those who live in urban areas.
The Federal Trade Commission (FTC) announced Tuesday that it is challenging hundreds of alleged “junk” patents held by drugmakers for 20 brand-name drugs, according to CNBC. Consequently, the FTC issued letters to 10 companies, including Novo Nordisk and AstraZeneca, to warn them that certain drug patents were improperly listed; many of the patents are for type 2 diabetes drugs, like Novo Nordisk’s semaglutide (Ozempic), or inhalers for chronic obstructive pulmonary disease (COPD). Most popular medications are protected by numerous patents, covering manufacturing processes, various ingredients, and intellectual property. Generic drugmakers can only launch cheaper versions of a branded drug if these patents expire or are successfully challenged in court. As a result, FTC Chair Lina Khan explained that “junk” patents block competition and inflate drug costs. By challenging these patents, the FTC is making sure Americans can get timely access to affordable versions of the medications they need.
The US Department of Agriculture (USDA) will begin testing ground beef for bird flu particles despite officials announcing that they are confident the meat supply is safe, according to the Associated Press. This is the latest effort by the USDA to track and understand how bird flu, also called Type A H5N1, is spreading among livestock; it has so far been identified in nearly 3 dozen dairy herds across 9 states. Two studies will test to see if ground beef for sale in states where dairy cows tested positive, or in states where particles were found in the muscles of dairy cows sent to slaughter, contain bird flu virus particles. Last week, the FDA announced it found noninfectious bird flu virus remnants in pasteurized milk, but scientists have not found evidence to suggest that people can get bird flu by consuming food that has been pasteurized or properly cooked.
A recent CDC report found that rural Americans are more likely to die early from 1 of the 5 leading causes of death than those who live in urban areas, according to ABC News. To determine this, the researchers looked at the number of potentially preventable deaths from 2010 through 2022. Compared with urbanities, rural Americans were more likely to die from heart disease, stroke, cancer, unintentional injuries, or chronic lower respiratory disease before age 80 years. The report also found that the percentage of preventable deaths, which they defined as those that occurred before age 80 years, was highest in rural counties versus urban ones. More specifically, 44% of premature heart disease deaths in rural areas were potentially preventable compared with 27% in urban areas; additionally, more than half of preventable deaths from unintentional injury and chronic lower respiratory disease in rural areas were preventable. Based on its findings, the CDC said it is trying to improve rural health through funding and guiding public health programs in rural communities, including promoting physical education in schools.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
From Red Tape to Relief: Rewriting the Rules of Prior Authorization
June 23rd 2025Up to 257 million Americans could benefit from these prior authorization reforms that could have cross-market implications on health care plans administered through commercial insurers, Medicare Advantage, and Medicaid.
Read More
RemeGen’s Telitacicept Gains China Approval for Myasthenia Gravis
June 19th 2025Telitacicept is a dual-targeting agent that attaches to and blocks the effects of 2 key signaling proteins, B-lymphocyte stimulator and a proliferation-inducing ligand, to treat the B-cell–mediated autoimmune disease, generalized myasthenia gravis.
Read More